The Immunomonitoring Laboratory (IML) was established within the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs (formerly CHiiPs) as an Interdisciplinary Research Center in December 2013.

The primary objective of the IML is to provide the structure, instrumentation and expertise to monitor the impact of immunotherapies on human and mouse immunologic profiles, and explore mechanisms and pathways related to treatment and disease models.

Our vision is to become a leader in the field of human immunology by establishing an environment where basic, translational and clinical aspects of human immunology and immunotherapy research are seamlessly integrated.

What sets us apart

State-of-the-art instrumentation

We offer a comprehensive suite of services in the areas of cytometry, immunoassays and tetramer development, including Phenocycler-Fusion, Luminex, Suspension and Imaging Mass Cytometry, and much more.

Highly accomplished lab staff

Our dedicated team offers unmatched expertise and experience in guiding your research endeavors, ensuring high-quality results and impactful discoveries.

Accessibility for all researchers

We welcome researchers from both within Washington University and external institutions, fostering collaboration and advancing our knowledge collectively.

Potential funding opportunities

All core lab services are eligible for the Just-In-Time (JIT) Core Usage Funding Program.